These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 6734205)

  • 21. Scanning and transmission electron microscopy of material adherent to intrauterine contraceptive devices.
    Sheppard BL; Bonnar J
    Br J Obstet Gynaecol; 1980 Feb; 87(2):155-62. PubMed ID: 7362803
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Incidence of infections associated with the intrauterine contraceptive device in an isolated community.
    Mead PB; Beecham JB; Maeck JV
    Am J Obstet Gynecol; 1976 May; 125(1):79-82. PubMed ID: 1275017
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Scanning electron microscopy of the IUD tail.
    Spornitz UM; Makabe S; Hafez ES; Van Os WA
    Contracept Deliv Syst; 1984 Jan; 5(1):29-45. PubMed ID: 12312743
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Dalkon Shield in perspective.
    Pendergast P; Hirsh HL
    Med Law; 1986; 5(1):35-44. PubMed ID: 3515100
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effect of different types of intrauterine devices on the risk of pelvic inflammatory disease.
    Kaufman DW; Watson J; Rosenberg L; Helmrich SP; Miller DR; Miettinen OS; Stolley PD; Shapiro S
    JAMA; 1983 Aug; 250(6):759-62. PubMed ID: 6876331
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Report on the sue of the Dalkon Shield intrauterine device.
    Sadovsky E; Yarkoni S; Anteby SO
    Contraception; 1974 Nov; 10(5):475-80. PubMed ID: 4448061
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Early postpartum insertion of an intrauterine device.
    Emens JM; Gustafson RC; Jordan JA
    Fertil Contracept; 1978 Jul; 2(3):38-41. PubMed ID: 12260722
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Dalkon Shield IUD.
    International Planned Parenthood Federation IPPF. International Medical Advisory Panel IMAP
    IPPF Med Bull; 1980 Dec; 14(6):3. PubMed ID: 12310088
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Type of intrauterine device and the risk of pelvic inflammatory disease.
    Lee NC; Rubin GL; Ory HW; Burkman RT
    Obstet Gynecol; 1983 Jul; 62(1):1-6. PubMed ID: 6856209
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Dalkon Shield, the TCu 200, and the TCu 380A in private practice.
    Thomas WO
    Trans Pac Coast Obstet Gynecol Soc; 1977; 44():78-85. PubMed ID: 335580
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fatal sepsis associated with an intrauterine device and pregnancy.
    Monif GR; D'Alessandri RM; Khakoo RA; Kluge RM
    South Med J; 1977 Feb; 70(2):249-50. PubMed ID: 320680
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intrauterine devices and pelvic inflammatory disease: recent developments.
    Grimes DA
    Contraception; 1987 Jul; 36(1):97-109. PubMed ID: 3311628
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Epidemiology of pelvic inflammatory disease in parous women with special reference to intrauterine device use.
    Buchan H; Villard-Mackintosh L; Vessey M; Yeates D; McPherson K
    Br J Obstet Gynaecol; 1990 Sep; 97(9):780-8. PubMed ID: 2242362
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Medical records in litigation: the Dalkon Shield story.
    Byrne K
    AMRO; 1992 Feb; 32(5):11-4. PubMed ID: 10117045
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Today's IUDs offer safe, effective contraception.
    Finger WR
    Netw Res Triangle Park N C; 1993 Mar; 13(3):12-5. PubMed ID: 12318094
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Dalkon Shield.
    FDA Consum; 1975 Feb; 9(1):21. PubMed ID: 10308671
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Translocation of the Dalkon Shield into the broad ligament.
    Cederqvist LL; Sarry ZI; Zervoudakis IA
    Obstet Gynecol; 1975 Aug; 46(2):239-42. PubMed ID: 1171420
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Letter: Intrauterine contraceptive devices.
    Watson DS
    Med J Aust; 1974 May; 1(20):811. PubMed ID: 4852831
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Factors affecting intrauterine contraceptive device performance. I. Endometrial cavity length.
    Hasson HM; Berger GS; Edelman DA
    Am J Obstet Gynecol; 1976 Dec; 126(8):973-81. PubMed ID: 998687
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Postpartum and postabortal insertion of intrauterine contraceptive devices.
    Martorella LA; Esposito JM
    J Reprod Med; 1975 Apr; 14(4):178-81. PubMed ID: 1142352
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.